Manlio Fusciello
8PUBLICATIONS
38CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Jan 28, 2026
Leveraging glucan-induced trained immunity for the epigenetic and metabolic rewiring of macrophages to enhance colorectal cancer vaccine response.Firas Hamdan, Sara Gandolfi, Federica D'Alessio
|Nov 12, 2025
Effect of extracellular vesicles in remodeling the tumor microenvironment by DNMT1 downregulation for enhanced cancer immunotherapy.Salvatore Russo, Yvonne Giannoula, Sara Feola
|Mar 08, 2024
Novel peptide-based oncolytic vaccine for enhancement of adaptive antitumor immune response via co-engagement of innate Fcγ and Fcα receptors.Sara Feola, Firas Hamdan, Salvatore Russo
|Nov 04, 2023
Development of mesothelioma-specific oncolytic immunotherapy enabled by immunopeptidomics of murine and human mesothelioma tumors.Jacopo Chiaro, Gabriella Antignani, Sara Feola
|Sep 25, 2021
β2-Integrin Adhesion Regulates Dendritic Cell Epigenetic and Transcriptional Landscapes to Restrict Dendritic Cell Maturation and Tumor Rejection.Carla Guenther, Imrul Faisal, Manlio Fusciello
|Aug 07, 2021
Novel oncolytic adenovirus expressing enhanced cross-hybrid IgGA Fc PD-L1 inhibitor activates multiple immune effector populations leading to enhanced tumor killing in vitro, in vivo and with patient-derived tumor organoids.Firas Hamdan, Erkko Ylösmäki, Jacopo Chiaro
Pageof 2
Frequent Collaborators
8 joint publications
Vincenzo Cerullo
6 joint publications
Sara Feola
5 joint publications
Firas Hamdan
3 joint publications
Erkko Ylösmäki
3 joint publications
Satu Mustjoki
2 joint publications
Salvatore Russo
2 joint publications
Michaela Feodoroff
2 joint publications
Jeanette Leusen
1 joint publications
Anni I Nieminen
1 joint publications
Mikaela Grönholm
